Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infection

Virology

Volumn 361, Issue 2, 2007, Pages 455-464

  Zhang, Zhi Qiang ^a   Casimiro, Danilo R ^a   Schleif, William A ^a   Chen, Minchun ^a   Citron, Michael ^a   Davies, Mary Ellen ^a   Burns, Janine ^a   Liang, Xiaoping ^a   Fu, Tong Ming ^a   Handt, Larry ^a   Emini, Emilio A ^a,b   Shiver, John W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PFIZER INC   (United States)

Author keywords

Germinal center; Immunohistochemistry; In situ hybridization; Lymph node; Proliferating B cells; Rapid progression; SIVmac239

Indexed keywords

VIRUS RNA;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL DISRUPTION; CELL PROLIFERATION; DISEASE COURSE; FOLLICULAR DENDRITIC CELL; GERMINAL CENTER; IN SITU HYBRIDIZATION; LYMPH NODE; MALE; NONHUMAN; PRIORITY JOURNAL; SAMPLE; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; BIOPSY; CELL COUNT; DISEASE PROGRESSION; GERMINAL CENTER; HYPERPLASIA; LYMPH NODES; MACACA MULATTA; MALE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 34147119210     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.12.006     Document Type: Article

References (37)

1. Baba T.W., Liska V., Hofmann-Lehmann R., Vlasak J., Xu W., Ayehunie S., Cavacini L.A., Posner M.R., Katinger H., Stiegler G., Bernacky B.J., Rizvi T.A., Schmidt R., Hill L.R., Keeling M.E., Lu Y., Wright J.E., Chou T.C., and Ruprecht R.M. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6 2 (2000) 200-206
2. Casimiro D.R., Wang F., Schleif W.A., Liang X., Zhang Z.Q., Tobery T.W., Davies M.E., McDermott A.B., O'Connor D.H., Fridman A., Bagchi A., Tussey L.G., Bett A.J., Finnefrock A.C., Fu T.M., Tang A., Wilson K.A., Chen M., Perry H.C., Heidecker G.J., Freed D.C., Carella A., Punt K.S., Sykes K.J., Huang L., Ausensi V.I., Bachinsky M., Sadasivan-Nair U., Watkins D.I., Emini E.A., and Shiver J.W. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. 79 24 (2005) 15547-15555
3. Dykhuizen M., Mitchen J.L., Montefiori D.C., Thomson J., Acker L., Lardy H., and Pauza C.D. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. J. Gen. Virol. 79 Pt 10 (1998) 2461-2467
4. Embretson J., Zupancic M., Ribas J.L., Burke A., Racz P., Tenner-Racz K., and Haase A.T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362 6418 (1993) 359-362
5. Fauci A.S. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262 5136 (1993) 1011-1018
6. Fauci A.S. Host factors and the pathogenesis of HIV-induced disease. Nature 384 6609 (1996) 529-534
7. Feinberg M.B. Changing the natural history of HIV disease. Lancet 348 9022 (1996) 239-246
8. Haase A.T., Henry K., Zupancic M., Sedgewick G., Faust R.A., Melroe H., Cavert W., Gebhard K., Staskus K., Zhang Z.Q., Dailey P.J., Balfour Jr. H.H., Erice A., and Perelson A.S. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274 5289 (1996) 985-989
9. Haigwood N.L., Watson A., Sutton W.F., McClure J., Lewis A., Ranchalis J., Travis B., Voss G., Letvin N.L., Hu S.L., Hirsch V.M., and Johnson P.R. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol. Lett. 51 1-2 (1996) 107-114
10. Haigwood N.L., Montefiori D.C., Sutton W.F., McClure J., Watson A.J., Voss G., Hirsch V.M., Richardson B.A., Letvin N.L., Hu S.L., and Johnson P.R. Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. J. Virol. 78 11 (2004) 5983-5995
11. + T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques. J. Virol. 78 1 (2004) 275-284
12. Imagawa D.T., Lee M.H., Wolinsky S.M., Sano K., Morales F., Kwok S., Sninsky J.J., Nishanian P.G., Giorgi J., Fahey J.L., et al. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N. Engl. J. Med. 320 22 (1989) 1458-1462
13. Liu S.L., Schacker T., Musey L., Shriner D., McElrath M.J., Corey L., and Mullins J.I. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71 6 (1997) 4284-4295
14. MacLennan I.C. Germinal centers. Annu. Rev. Immunol. 12 (1994) 117-139
15. + T cells and circulating in plasma. J. Virol. 76 17 (2002) 8855-8863
16. + lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype. J. Virol. 79 23 (2005) 14887-14898
17. Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L., and Lewis M.G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6 2 (2000) 207-210
18. Michael N.L., Brown A.E., Voigt R.F., Frankel S.S., Mascola J.R., Brothers K.S., Louder M., Birx D.L., and Cassol S.A. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection-evidence for highly susceptible human hosts. J. Infect. Dis. 175 6 (1997) 1352-1359
19. Moir S., Malaspina A., Li Y., Chun T.W., Lowe T., Adelsberger J., Baseler M., Ehler L.A., Liu S., Davey Jr. R.T., Mican J.A., and Fauci A.S. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J. Exp. Med. 192 5 (2000) 637-646
20. Moir S., Malaspina A., Ogwaro K.M., Donoghue E.T., Hallahan C.W., Ehler L.A., Liu S., Adelsberger J., Lapointe R., Hwu P., Baseler M., Orenstein J.M., Chun T.W., Mican J.A., and Fauci A.S. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc. Natl. Acad. Sci. U. S. A. 98 18 (2001) 10362-10367
21. + T cell help in HIV-infected individuals. Proc. Natl. Acad. Sci. U. S. A. 100 10 (2003) 6057-6062
22. Moir S., Malaspina A., Pickeral O.K., Donoghue E.T., Vasquez J., Miller N.J., Krishnan S.R., Planta M.A., Turney J.F., Justement J.S., Kottilil S., Dybul M., Mican J.M., Kovacs C., Chun T.W., Birse C.E., and Fauci A.S. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J. Exp. Med. 200 5 (2004) 587-599
23. Nishimura Y., Igarashi T., Haigwood N., Sadjadpour R., Plishka R.J., Buckler-White A., Shibata R., and Martin M.A. Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J. Virol. 76 5 (2002) 2123-2130
24. Pantaleo G., Graziosi C., Demarest J.F., Butini L., Montroni M., Fox C.H., Orenstein J.M., Kotler D.P., and Fauci A.S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362 6418 (1993) 355-358
25. Parren P.W., Marx P.A., Hessell A.J., Luckay A., Harouse J., Cheng-Mayer C., Moore J.P., and Burton D.R. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75 17 (2001) 8340-8347
26. + memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 200 10 (2004) 1299-1314
27. Ryzhova E., Whitbeck J.C., Canziani G., Westmoreland S.V., Cohen G.H., Eisenberg R.J., Lackner A., and Gonzalez-Scarano F. Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4. J. Virol. 76 15 (2002) 7903-7909
28. Schmitz J., van Lunzen J., Tenner-Racz K., Grossschupff G., Racz P., Schmitz H., Dietrich M., and Hufert F.T. Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. J. Immunol. 153 3 (1994) 1352-1359
29. Schmitz J.E., Kuroda M.J., Santra S., Simon M.A., Lifton M.A., Lin W., Khunkhun R., Piatak M., Lifson J.D., Grosschupff G., Gelman R.S., Racz P., Tenner-Racz K., Mansfield K.A., Letvin N.L., Montefiori D.C., and Reimann K.A. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 77 3 (2003) 2165-2173
30. Smith S.M., Holland B., Russo C., Dailey P.J., Marx P.A., and Connor R.I. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression. AIDS Res. Hum. Retroviruses 15 18 (1999) 1691-1701
31. +-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques. J. Virol. 72 2 (1998) 1600-1605
32. Szakal A.K., Kosco M.H., and Tew J.G. Microanatomy of lymphoid tissue during humoral immune responses: structure function relationships. Annu. Rev. Immunol. 7 (1989) 91-109
33. Tenner-Racz K., and Racz P. Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficiency virus. Curr. Top. Microbiol. Immunol. 201 (1995) 141-159
34. Watson A., Ranchalis J., Travis B., McClure J., Sutton W., Johnson P.R., Hu S.L., and Haigwood N.L. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71 1 (1997) 284-290
35. + T cells. Science 286 5443 (1999) 1353-1357
36. Zhang Z.Q., Fu T.M., Casimiro D.R., Davies M.E., Liang X., Schleif W.A., Handt L., Tussey L., Chen M., Tang A., Wilson K.A., Trigona W.L., Freed D.C., Tan C.Y., Horton M., Emini E.A., and Shiver J.W. Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection. J. Virol. 76 24 (2002) 12845-12854
37. Zhang Z.Q., Schleif W.A., Casimiro D.R., Handt L., Chen M., Davies M.E., Liang X., Fu T.M., Tang A., Wilson K.A., McElhaugh M., Carella A., Tan C., Connolly B., Hill S., Klein H., Emini E.A., and Shiver J.W. The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P. Virology 320 1 (2004) 75-84